Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Morales

Showing results (111-120 of 151) with videos related to

Pageof 16
Sort By:
International Journal of Molecular Sciences|February 11, 2023
Effects of a Novel Infant Formula on the Fecal Microbiota in the First Six Months of Life: The INNOVA 2020 StudyFrancisco Javier Ruiz-Ojeda, Julio Plaza-Diaz, Javier Morales, et al.
International Journal of Molecular Sciences|April 28, 2023
Innova 2020: A Follow-Up Study of the Fecal Microbiota of Infants Using a Novel Infant Formula between 6 Months and 12 Months of AgeJulio Plaza-Diaz, Francisco Javier Ruiz-Ojeda, Javier Morales, et al.
Medicina Clinica|May 31, 2024
[Classification tree obtained by artificial intelligence for the prediction of heart failure after acute coronary syndromes]Alberto Cordero, Vicente Bertomeu-Gonzalez, José V Segura, et al.
Plos One|October 24, 2018
Safety, efficacy, and dose response of the maturation inhibitor GSK3532795 (formerly known as BMS-955176) plus tenofovir/emtricitabine once daily in treatment-naive HIV-1-infected adults: Week 24 primary analysis from a randomized Phase IIb trialJavier Morales-Ramirez, Johannes R Bogner, Jean-Michel Molina, et al.
European Journal of Orthopaedic Surgery & Traumatology : Orthopedie Traumatologie|September 24, 2024
Comparative risk of ulnar nerve injury in pediatric supracondylar humeral fractures: a multicenter evaluation of Kirschner wire fixation techniquesOscar Javier Morales-Guerrero, María Fernanda Garcia-Rueda, Camilo Mendoza-Pulido, et al.
Vaccines|September 28, 2021
Neutralizing Antibodies against SARS-CoV-2, Anti-Ad5 Antibodies, and Reactogenicity in Response to Ad5-nCoV (CanSino Biologics) Vaccine in Individuals with and without Prior SARS-CoV-2Jorge Hernández-Bello, José Javier Morales-Núñez, Andrea Carolina Machado-Sulbarán, et al.
Journal of Clinical Laboratory Analysis|November 24, 2020
Metabolic syndrome in rheumatoid arthritis patients: Relationship among its clinical componentsMariel García-Chagollán, Susana Elizabeth Hernández-Martínez, Alma Elizabeth Rojas-Romero, et al.
Advances in Radiation Oncology|January 17, 2022
Positron Emission Tomography-Derived Metrics Predict the Probability of Local Relapse After Oligometastasis-Directed Ablative Radiation TherapyCarlo Greco, Oriol Pares, Nuno Pimentel, et al.
Journal of Inflammation Research|August 12, 2022
Differences in B-Cell Immunophenotypes and Neutralizing Antibodies Against SARS-CoV-2 After Administration of BNT162b2 (Pfizer-BioNTech) Vaccine in Individuals with and without Prior COVID-19 - A Prospective Cohort StudyJosé Javier Morales-Núñez, Mariel García-Chagollán, José Francisco Muñoz-Valle, et al.
Antimicrobial Agents and Chemotherapy|March 9, 2023
Development of Nanobodies as Theranostic Agents against CMY-2-Like Class C β-LactamasesFrédéric Cawez, Paola Sandra Mercuri, Francisco Javier Morales-Yãnez, et al.
Pageof 16

Showing results (111-120 of 151) with videos related to

Sort By:
Pageof 16
International Journal of Molecular Sciences|February 11, 2023
Effects of a Novel Infant Formula on the Fecal Microbiota in the First Six Months of Life: The INNOVA 2020 StudyFrancisco Javier Ruiz-Ojeda, Julio Plaza-Diaz, Javier Morales, et al.
International Journal of Molecular Sciences|April 28, 2023
Innova 2020: A Follow-Up Study of the Fecal Microbiota of Infants Using a Novel Infant Formula between 6 Months and 12 Months of AgeJulio Plaza-Diaz, Francisco Javier Ruiz-Ojeda, Javier Morales, et al.
Medicina Clinica|May 31, 2024
[Classification tree obtained by artificial intelligence for the prediction of heart failure after acute coronary syndromes]Alberto Cordero, Vicente Bertomeu-Gonzalez, José V Segura, et al.
Plos One|October 24, 2018
Safety, efficacy, and dose response of the maturation inhibitor GSK3532795 (formerly known as BMS-955176) plus tenofovir/emtricitabine once daily in treatment-naive HIV-1-infected adults: Week 24 primary analysis from a randomized Phase IIb trialJavier Morales-Ramirez, Johannes R Bogner, Jean-Michel Molina, et al.
European Journal of Orthopaedic Surgery & Traumatology : Orthopedie Traumatologie|September 24, 2024
Comparative risk of ulnar nerve injury in pediatric supracondylar humeral fractures: a multicenter evaluation of Kirschner wire fixation techniquesOscar Javier Morales-Guerrero, María Fernanda Garcia-Rueda, Camilo Mendoza-Pulido, et al.
Vaccines|September 28, 2021
Neutralizing Antibodies against SARS-CoV-2, Anti-Ad5 Antibodies, and Reactogenicity in Response to Ad5-nCoV (CanSino Biologics) Vaccine in Individuals with and without Prior SARS-CoV-2Jorge Hernández-Bello, José Javier Morales-Núñez, Andrea Carolina Machado-Sulbarán, et al.
Journal of Clinical Laboratory Analysis|November 24, 2020
Metabolic syndrome in rheumatoid arthritis patients: Relationship among its clinical componentsMariel García-Chagollán, Susana Elizabeth Hernández-Martínez, Alma Elizabeth Rojas-Romero, et al.
Advances in Radiation Oncology|January 17, 2022
Positron Emission Tomography-Derived Metrics Predict the Probability of Local Relapse After Oligometastasis-Directed Ablative Radiation TherapyCarlo Greco, Oriol Pares, Nuno Pimentel, et al.
Journal of Inflammation Research|August 12, 2022
Differences in B-Cell Immunophenotypes and Neutralizing Antibodies Against SARS-CoV-2 After Administration of BNT162b2 (Pfizer-BioNTech) Vaccine in Individuals with and without Prior COVID-19 - A Prospective Cohort StudyJosé Javier Morales-Núñez, Mariel García-Chagollán, José Francisco Muñoz-Valle, et al.
Antimicrobial Agents and Chemotherapy|March 9, 2023
Development of Nanobodies as Theranostic Agents against CMY-2-Like Class C β-LactamasesFrédéric Cawez, Paola Sandra Mercuri, Francisco Javier Morales-Yãnez, et al.
Pageof 16